t(9;22) as secondary alteration in core‐binding factor de novo acute myeloid leukemia

E-ISSN： 1096-8652|90|11|E211-E212

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.90, Iss.11, 2015-11, pp. : E211-E212

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Translocation t(11;17) in de novo Myelodysplastic Syndrome Not Associated with Acute Myeloid or Acute Promyelocytic Leukemia

Acta Haematologica, Vol. 129, Iss. 1, 2012-11 ,pp. : 48-54

Karger

Access to resources Recommend Favorite

Jumping translocation in a case of De novo infant acute myeloid leukemia

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 61, Iss. 2, 2014-02 ,pp. : 387-389

John Wiley & Sons Inc

Access to resources Recommend Favorite

Coexpression of NUP98/TOP1 and TOP1/NUP98 in de novo Acute Myeloid Leukemia with t(11;20)(p15;q12) and t(2;5)(q33;q31)

Cytogenetic and Genome Research, Vol. 150, Iss. 3-4, 2017-03 ,pp. : 287-292

Karger

Access to resources Recommend Favorite

De novo Acute Myeloid Leukemia Associated with t(11;17)(q23;q25) and MLL-SEPT9 Rearrangement in an Elderly Patient: A Case Study and Review of the Literature

Acta Haematologica, Vol. 126, Iss. 4, 2011-08 ,pp. : 195-198

Karger

Access to resources Recommend Favorite

Prolonged Survival with Imatinib Mesylate Combined with Chemotherapy and Allogeneic Stem Cell Transplantation in de novo Ph+ Acute Myeloid Leukemia

Acta Haematologica, Vol. 127, Iss. 3, 2012-01 ,pp. : 143-148

Karger

Access to resources Recommend Favorite